Fast-Paced Growth In -Use Adoption To Propel Gene Delivery Systems Market Revenue Growth : Fact.MR

As per the latest industry analysis by Fact.MR, a market research and competitive intelligence provider, global demand for gene delivery systems is forecasted to increase rapidly at a CAGR of 6.5% from 2022 to 2027.

The requirement for advanced technologies for targeted therapies is driving the global market for gene delivery systems. The introduction of new and cutting-edge technologies and the rise in the prevalence of chronic diseases are the key drivers for market growth. Growing research and development activities in genomics have also been a major factor driving market expansion. Rising preference among patients for modern products and innovative drug delivery systems, because of these products’ increased efficacy and precision, is predicted to boost market value over the coming years.

The oral route of administration is a cost-effective, painless, and self-administered delivery method that does not require sterile precautions. Market expansion is being boosted by the discovery of new therapies that can recognize afflicted cells and can treat them without damaging the healthy cells. Market growth is also attributed to the quick development of biosimilars, targeted treatments, and gene therapies.

A surge in investments in the sector are supporting the production of various mechanisms of gene transfer. Currently, viral vectors are used in over 70% of gene and cell therapy studies, which is driving organic revenue growth for biological delivery technologies.

For critical insights on this market, request for More Info –

Segments of Gene Delivery Systems Industry Research

  • By Delivery :

    • Viral Gene Delivery
    • Non-viral Gene Delivery
  • By Route of Administration :

    • Oral
    • Injectable
    • Inhalation
    • Transdermal
    • Ocular
    • Nasal
    • Others
  • By Application :

    • Infectious Diseases
    • Oncology
    • CVD
    • Urology
    • CNS
    • Others
  • By Region :

    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Request more information about Report Methodology –

Key Takeaways from Market Study

  • The gene delivery systems market in Japan is projected to evolve at a CAGR of 6% over the forecast period (2022-2027).
  • The global gene delivery systems market is predicted to reach US$ 4.1 billion by 2027.
  • Market in Germany is forecasted to rise at a CAGR of 5.5% through 2027.
  • Demand for non-viral gene delivery systems is predicted to increase at a CAGR of 4.5% from 2022 to 2027.

Winning Strategy

Top market players are making major investments to expand their viral vector production capacity and keep up with the rising demand. Major players in the genomics industry are focused on the introduction of innovative gene delivery systems. Key companies are engaged in the R&D and commercialization of advanced therapies.

For instance,

  • In 2021, Thermogelling peptide delivery methods, which are given as fluid sol at room temperature through an injection, were created by Novartis AG. The company also manufactures ZYKADIA, a medication for the treatment of non-small cell lung cancer.